Current and future challenges of antithrombotic agents and anticoagulants: Strategies for reversal of hemorrhagic complications.
about
Direct thrombin inhibitors: pharmacology and clinical relevance.Polyphosphate as a general procoagulant agent.The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants.Newer antithrombotic drugs
P2860
Current and future challenges of antithrombotic agents and anticoagulants: Strategies for reversal of hemorrhagic complications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Current and future challenges ...... of hemorrhagic complications.
@ast
Current and future challenges ...... of hemorrhagic complications.
@en
type
label
Current and future challenges ...... of hemorrhagic complications.
@ast
Current and future challenges ...... of hemorrhagic complications.
@en
prefLabel
Current and future challenges ...... of hemorrhagic complications.
@ast
Current and future challenges ...... of hemorrhagic complications.
@en
P1476
Current and future challenges ...... of hemorrhagic complications.
@en
P2093
Craig M Kessler
P356
10.1053/J.SEMINHEMATOL.2003.11.010
P433
P577
2004-01-01T00:00:00Z